Background and aims-The colons of patients with pneumatosis cystoides coli produce excessive H 2. Exposure to alkyl halides could explain this. Six consecutive patients who had pneumatosis cystoides coli while taking chloral hydrate (1-5+ g/day) are reported. Patients 2 and 3 were investigated after they had ceased chloral hydrate treatment. One produced methane, the other did not. (Pneumatosis cystoides coli patients are non-methanogenic according to the literature.) Both had overnight fasting breath H 2 of less than 10 ppm. A literature review disclosed just one patient who was using chloral at the time of diagnosed pneumatosis cystoides coli, but an epidemic of the disease in workers exposed to trichloroethylene.
Pneumatosis cystoides intestinalis is a rare disorder which is characterised pathologically by the presence of gas-filled cysts in the walls and mesentery of the small or large intestine.
1-5 The cysts are found near blood vessels mostly on the mesenteric border. 3 5 6 Pneumatosis cystoides intestinalis aVecting the small intestine has commonly been reported in association with organic intestinal obstruction-for example, pyloric stenosis 2 7 and Crohn's stricture 3 -or functional pseudo-obstruction. [8] [9] [10] Acute pneumatosis cystoides intestinalis has also been described in neonates with necrotising enterocolitis 5 and in immunocompromised children 11 and adults. 12 13 Invasion of the gut wall by gas-forming bacteria undoubtedly occurs in these settings of overwhelming gut infection or severely compromised immune function.
On the other hand, pneumatosis cystoides intestinalis that is confined to the colon, pneumatosis cystoides coli (PCC), has been reported mainly in an older population. 4 9 14-19 There is no recognised predisposing causethat is, PCC has been characterised as a primary idiopathic condition-and, in particular, bacteria are not seen in the gut wall or mesentery with PCC. 18 Association with chronic pulmonary disease 6 has led to speculation about a possible relationship to changes in blood gas tensions. 9 An account of the pathogenesis of PCC must explain (a) why the cysts form ab initio, (b) why the cysts are then maintained in the colonic wall and mesentery, (c) why the cysts contain H 2 gas 9 14 15 but not CH 4 , 1 9 (d) why PCC patients are super H 2 producers, 4 14 16 17 and (e) the epidemiology of the disease.
There is theoretical and experimental evidence that gas cysts can form by counterperfusion supersaturation of metabolically inert gases, 20 which would explain (a), (b) and (c). Counterperfusion supersaturation of gases is analogous to a form of decompression sickness in deep sea divers but where there is normal atmospheric pressure. 20 It would occur in the colon only if H 2 gas pressure in the lumen were so high as to be equal and opposite to N 2 gas pressure in the blood. This condition does not occur in normal humans, where metabolism of colonic bacteria produces H 2 , but luminal H 2 tension remains less than N 2 tension in the colonic lumen. 21 This is because H 2 tension is reduced by a combination of H 2 consumption by bacteria, [22] [23] [24] H 2 excretion in flatus or breath, 25 26 and N 2 , which by entering the lumen, dilutes H 2 tension. N 2 may enter the gastrointestinal lumen via diVusion from blood and tissue 20 or via swallowed air. 27 On the other hand, super H 2 production by colonic bacteria, which occurs in patients with PCC, provides the condition for H 2 tension in the colonic lumen to approach the level of N 2 tension in blood.
This permits counterperfusion supersaturation, 20 which can occur provided that the inherent unsaturation of tissue due to metabolism of O 2 is significantly less than the peak supersaturation due to opposing gradients of H 2 and N 2 .
20 It remains to be explained why patients with PCC are super H 2 producers 4 14 16 17 and the epidemiology of this rare disorder.
This study comprises clinical and experimental data, which demonstrate why many patients with PCC are super H 2 producers. Six consecutive cases of PCC are reported. Three were investigated by the author. All six were prescribed chloral hydrate, 1-5+ g/day. Chloral, which is probably the oldest synthetic chemical used in hypnotic drug therapy, is rapidly metabolised to trichloroethanol, the metabolite responsible for its hypnotic action. 28 The plasma half-life of trichloroethanol in humans is eight hours. 29 Other metabolites of chloral hydrate include trichloroacetic acid and trichloroethanoglucuronide, which is excreted by the liver. 30 These compounds are alkyl halides like trichloroethylene and chloroform. It is relevant that trichloroethylene, which is used in the watch-making and camera industry, was recently associated with an epidemic of PCC in Japan. 31 Trichloroethylene is also metabolised by the liver to trichloroethanol and trichloroacetic acid.
The eVect of these alkyl halides on net H 2 production was examined in vitro in human faecal cultures and in vivo in an animal model. The data predict why humans exposed to alkyl halides would become super H 2 producers, and are discussed in relation to the pathogenesis of idiopathic PCC and small intestinal pneumatosis cystoides.
Patients and Methods

PATIENT 1
An 83 year old female nursing home patient presented to the author with confusion and dehydration in 1989. She was incontinent of faeces which were noted to be blood-stained. She was on -blocker therapy for hypertension, haloperidol and chloral hydrate 1-2 g nocte. Flexible sigmoidoscopy showed characteristic PCC cysts in the sigmoid colon, which were about 0.5-1 cm in diameter and which made a hissing sound when punctured with a biopsy forceps. Her faeces were weakly methanogenic (see below). Fasting H 2 breath, which is abnormally high in PCC, 4 14 16 17 was 34 ppm. Breath CH 4 was not measured. The patient received no specific treatment and died shortly after. PATIENT 2 This female patient (date of birth 15 October 1928) had been well until 1972, when she suffered the unexpected death of a family member. She was prescribed diazepam and chloral hydrate at the time of the bereavement to help her sleep. In 1974, the patient was referred to a gastroenterologist; she had a six month history of altered bowel habit, mucus, and occasional blood. Plain abdominal radiographs and barium enema investigation showed PCC involving the sigmoid and descending colon. She received antibiotics and oxygen therapy between 1975 and 1982 but treatment responses were not sustained. A progress barium study in 1986 showed extensive PCC.
In 1994, patient 2 was seen by the author. Directed questioning revealed that she had been addicted to benzodiazepines and chloral hydrate. She reported using in excess of 50 ml of 10 g/% chloral hydrate daily between 1975 and 1988. Sedation treatments were stopped in 1988, so that her medication in 1994 comprised dyazide, fosinopril for hypertension, thyroxine, lithium carbonate for depression, and oestrone hormone replacement therapy. A plain abdominal radiograph showed a normal intestinal gas pattern. Pale white plaques, the histology of which was reported as showing non-specific changes, were noted in the sigmoid and descending colon at colonoscopy. There were no cysts. The faeces were strongly methanogenic, and breath CH 4 concentration was greater than 20 ppm above ambient on two occasions. Fasting breath H 2 was less than 10 ppm on these occasions. PATIENT 3 This woman (date of birth 14 January 1923) had a past history of uncomplicated duodenal ulcer disease for which she was prescribed a course of ranitidine in 1981. In 1984, she was prescribed valium 5 mg daily and chloral hydrate (10 g/%) 12 ml nocte for an anxiety disorder. A chest radiograph was normal in 1988. In 1991 when investigated by colonoscopy for abdominal bloating, she was documented as having severe left sided PCC. This was not treated. Chloral hydrate was ceased in September 1993. A second colonoscopy in March 1996 showed no cysts and was reported by the colonoscopist as showing "plaques of white tissue resembling deflated air pockets". Her medication at that time comprised atenolol, doxepin, temazepam, clonazepam, donnatabs, and ranitidine. She went on to have "triple" therapy to eradicate Helicobacter pylori. Six weeks after completion of triple therapy, she was seen by the author. Fasting breath CH 4 was equal to ambient CH 4 , breath H 2 was 4 ppm, and her faeces were non-methanogenic (<20 ppm after four hour anaerobic culture). PATIENT 4 This woman (date of birth 5 June 1915), with a history of epilepsy since the age of two and mild mental retardation, was one of just three patients with PCC diagnosed by colonoscopy at the Princess Alexandra Hospital between tained by Dr Andrew Pascoe, who searched the hospital's pathology records under the diagnostic heading of PCC. Patient 4 was prescribed chloral hydrate (10 g/%) 10-20 ml nocte for sleep in addition to phenobarbitone and dilantin for epilepsy. PATIENT 5 This male patient (date of birth 21 February 1911), with a past history of bilateral inguinal hernia repair, benign prostatomegaly, and mycosis fungoides, took oxazepam and chloral hydrate to sleep. PATIENT 6 Detailed clinical records are not available for this female patient (date of birth 3 January 1939), but pharmacy sheets from the Princess Alexandra Hospital indicated that she also was prescribed chloral hydrate.
STUDY OF EFFECT OF ALKYL HALIDES ON FAECAL H 2 AND CH 4 METABOLISM
In vitro human faecal studies Stools 23 were collected from four CH 4 -producing subjects (three healthy volunteers and patient 2) and three non-methanogenic subjects (two healthy volunteers and patient 3). BuVered 5% (w/v) faecal suspensions were prepared within two hours of collection and cultured anaerobically for 24 hours to mimic the substrate-poor conditions of the left colon. 23 Cultures were grown in gas-tight butyl rubber-stoppered glass bottles. The concentration of bacteria in the anaerobic 5% (w/v) faecal batch cultures falls between the concentration of anaerobic bacteria in the caecum and rectum. 32 Chloral hydrate, trichloroethanol, trichloroaceticacid,trichloroethylene,orchloroform was added at diVerent concentrations (1, 10, 10 2 , 10 3 , 10 4 , 10 5 , and 3×10 5 µM) to the buVered anaerobic faecal cultures. Control cultures received Hepes buVer only. H 2 was measured electrochemically, and CH 4 was determined by gas chromatography on 1 ml gas samples aspirated from the culture headspace at 4 and 24 hours. 23 A CH 4 -producing-that is, methanogenic culture-was defined by a headspace CH 4 concentration greater than 1000 ppm at four hours, and non-methanogenesis by a headspace CH 4 concentration of less than 20 ppm at four hours.
In vivo animal experiment
Four adult female Wistar rats (200-250 g) were given chloral hydrate (200 mg/%) in their drinking water. These rats, which came from the University of Queensland Central Anima1 Breeding House, do not harbour significant methanogens. Net faecal H 2 production (as inferred from headspace H 2 concentration) was measured in four hour cultures 3, 8, 15 and 22 days after commencement of the chloral hydrate regimen, and was compared with net faecal H 2 production in littermate female controls kept in separate cages. Two rats from each group were killed on day 23 by a lethal inhaled dose of isoflurane and then intestines were removed for macroscopic examination. They were Swiss-rolled, fixed in formalin, embedded in paraYn, sectioned, and stained for light microscopic examination by a trained histopathologist. The remaining rats were then switched to the control drinking regimen-that is, tap water-but continued to be caged separately.
STATISTICAL ANALYSIS
Instat non-parametric analysis software (Instat version 2.01 for MacIntosh) was used to determine statistical significance of diVerences between sample means. Significance was assumed if two-tailed p<0.05.
ETHICAL APPROVAL
The project was approved by the Mater Adult Hospital Ethics Committee, which is constituted according to Australian NH&MRC guidelines.
Results
With respect to methanogenic control cultures, mean H 2 concentration at four hours was 180 ppm, and at 24 hours it was 10 ppm or less. Mean CH 4 at four hours was 2100 ppm, and at 24 hours it was 6500 ppm (fig lA) . With respect to non-methanogenic control cultures, mean H 2 concentration at four hours was 900 ppm, and at 24 hours it was 550 ppm. Mean CH 4 at four hours was 6 ppm, and at 24 hours it was 10 ppm (fig lB) . Thus there was on average at four hours, five times more H 2 in nonmethanogenic cultures, and at 24 hours, more than 55 times more H 2 in non-methanogenic cultures compared with methanogenic cultures. 4 µM) increased H 2 equally (p = 0.45) over control levels and four times more than trichloroacetic acid or trichloroethylene in methanogenic cultures (p = 0.02), and two times more than trichloroacetic acid or trichloroethylene in non-methanogenic culture experiments (p = 0.03). There was no diVerence detected between H 2 concentrations in methanogenic faecal cultures derived from a former PCC subject versus methanogenic faeces from non-PCC subjects or non-methanogenic faecal cultures derived from a former PCC subject versus non-methanogenic faecal cultures from non-PCC subjects (p>0.45). Table 1 shows mean maximum H 2 for methanogenic and non-methanogenic culture experiments. Data are expressed as a ratio of H 2 in alkyl halide-amended cultures to that in unamended control cultures. For methanogenic cultures with chloral hydrate or trichloroethanol (n = 8), mean maximum H 2 production was 240 times control levels and for non-methanogenic cultures (n = 6) 3.8 times control levels. Trichloroacetic acid or trichloroethylene increased net H 2 55 times in methanogenic cultures (n = 8), and 2.0 times control H 2 levels in non-methanogenic cultures (n = 6). The diVerences in maximum net H 2 between each of the groups were statistically significant (p<0.03). In a single experiment with chloroform using faeces from non-PCC donors, H 2 was increased 180 times in a methanogenic culture (n = 1) and 1.9 times control levels in a non-methanogenic culture (n = 1). Figure 2 shows mean H 2 in alkyl halideamended cultures relative to H 2 in control cultures at four hours, versus alkyl halide concentrations (1-10 5 µM). K i values were calculated from data pooled from all methanogenic and non-methanogenic cultures for each alkyl halide and by assuming that the kinetics of inhibition of bacterial consumption of H 2 was linear over the four hours. The K i for chloral hydrate,trichloroethanol,chloroform,trichloroethylene, and trichloroacetic acid were respectively 0.2, 0.03, 0.3, 0.4, and 3 mM.
Inhibition of CH 4 formation in methanogenic cultures by alkyl halides was maximal at [alkyl halide] = 10 3 -10 4 µM, corresponding to the alkyl halide concentration that resulted in maximum H 2 . At this concentration, chloral hydrate and trichloroethanol both depressed CH 4 levels to 110 (50-640) times less than control levels (p = 0.005), and trichloroacetic acid and trichloroethylene depressed CH 4 levels 6 (4.5-10) fold (p = 0.009). Methanogen bacteria produce 1 mol of CH 4 from oxidation of 4 mol of H 2 . Thus the expected ratio of excess H 2 to deficit CH 4 caused by inhibition of H 2 oxidation by methanogens is 4, but the experimental mean of excess H 2 /deficit CH 4 was 10.4. There was considerable intraexperimental variation in this ratio, which was not statistically significant for the alkyl halide species or their concentration (0.1-10 mM). The median (range) of excess H 2 /deficit CH 4 was 7 (0.6-31).
The Wistar rats that had chloral hydrate added to their drinking water, drank on average 8 ml fluid/day compared with 11 ml/day by controls. The behaviour of the rats that drank the chloral hydrate (<0.08g/kg per day)-amended water did not appear to be diVerent from controls-that is, they were not drowsy or less active, did not lose weight or condition, and did not develop altered bowel habit over 23 days of exposure to chloral or during the subsequent washout period. Net faecal H 2 production by rats fed chloral hydrate was 10 times that of controls from day 3 (the first day faecal pellets were collected after commencement of chloral hydrate) and throughout the period of chloral administration (fig 3) . Macroscopic and microscopic examination of intestines from two rats from each group did not show pneumatosis or any other significant finding. Net faecal H 2 production fell towards control levels during the washout period, although they remained significantly elevated over the period of observation.
Discussion
The principal findings of this study were (a) the striking clinical observation that six consecutively ascertained PCC patients were taking chloral hydrate at the time of their diagnosis, (b) the greater H 2 consumption by methanogenic than non-methanogenic human faecal cultures, (c) the dramatic increase in net H 2 production by in vitro human faeces with added alkyl halides, (d) the parity of maximum net H 2 production by methanogenic and non-methanogenic faeces with added alkyl halide, (e) the reciprocal decrease in CH 4 production by methanogenic faeces with alkyl halide, and (f) the dramatic increase in net H 2 production by faeces, which resulted from chloral hydrate ingestion in the in vivo rat model. The major negative finding of the study was the absence of pneumatosis cystoides in the rat model. Of the six consecutively ascertained patients with PCC, all were taking chloral hydrate. There is a report in the PCC literature 33 of a patient who was noted to be taking chloral hydrate. This also happens to be the only reported instance of familial PCC. It involved a mother, who was taking chloral hydrate, and her son, who had a psychiatric illness. There is also the hitherto unexplained epidemiological relation between exposure to trichloroethylene and PCC in Japan. 31 Trichloroethylene is metabolised in the liver to trichloroethanol, the main active metabolite of chloral hydrate.
The bacteria in control faecal cultures produced H 2 , which by 24 hours was consumed in methanogenic cultures (fig lA) , but not in the non-methanogenic faecal cultures from humans (fig lB) . The methanogenic cultures were about 55 times more eYcient at consuming H 2 than non-methanogenic cultures. This is consistent with data from most research workers in the field, who have observed methanogenic faecal bacteria to consume H 2 more eYciently than nonmethanogenic faecal bacteria, 22-24 34 and methanogenic humans to excrete less H 2 than non-methanogenic humans. 35 The principal H 2 -consuming bacteria in the human colon are methanogens in methanogenic individuals 23 34 and acetogens in non-methanogenic humans. 22 24 The latter are less eYcient at H 2 consumption than methanogens, which explains why non-methanogenic humans produce more net H 2 than methanogenic humans.
Net H 2 was increased many-fold over control levels in the in vitro faecal cultures exposed to various alkyl halides (>1 µM), although at very high concentrations (>100 mM), the data show that H 2 was depressed in nonmethanogenic faecal cultures. Reports of methanogenic (but not acetogenic) consortia, or even pure methanogen cultures, catabolising alkyl halides such as chloroform 36 might explain why the methanogenic (but not nonmethanogenic) faecal cultures in this study tolerated very high concentrations of the alkyl halides.
These alkyl halides with molecular masses from 119 Da (chloroform) to 165 Da (chloral hydrate) are chemically similar. Chloroform is known to inhibit acetogens 37 and methanogens. 36 In this study, there was a profound inhibition of methanogenesis in concert with the increase in net H 2 . Thus the experimental data suggest that alkyl halides of comparable molecular mass behave like chloroform. Although acetogenesis was not measured, its inhibition by alkyl halides can be inferred because there was a significant increase in net H 2 produced by the nonmethanogenic cultures with alkyl halides. The data are also consistent with the occurrence of acetogenesis in methanogenic cultures 24 because the ratio of excess H 2 /deficit CH 4 was often in excess of 4 (the expected stoichiometric ratio for methanogenesis).
The 10-fold increase in net H 2 production by faeces, which resulted from chloral hydrate ingestion in the rat model (fig 3) , occurred in non-methanogenic faeces. This is quantitatively similar to the situation with the in vitro non-methanogenic human faecal cultures. The in vivo eVect was apparent within three days of commencement of the chloral hydrate regime and was partially reversed within one day of stopping it.
Can it be inferred from these data that ingestion of chloral causes reversible super H 2 production in humans? The answer must surely be in the aYrmative. Patient 2 admitted [24] [25] [26] [27] [28] [29] [30] and control (days [24] [25] [26] [27] [28] [29] [30] . to ingesting greater than the recommended prescribed dose of chloral hydrate, which is addictive and subject to tachyphylaxis. By assuming that trichloroethanol has a volume of distribution equivalent to total body weight, it is calculated that the peak concentration of trichloroethanol in the colon, which could result from patient 2 ingesting 0. 1) , so that H 2 concentrations were nearly identical when bacterial consumption of H 2 was maximally inhibited in the two groups. These data are consistent with other studies which have shown that non-methanogenic cultures are inherently less eYcient at consuming H 2 than methanogenic cultures, 22-24 34 but that the total production of H 2 by bacteria in the two culture groups is similar. 23 Thus exposure to these alkyl halides makes it possible for super H 2 production to occur in either methanogenic or non-methanogenic faeces. This conclusion that super H 2 production can occur in either methanogenic or non-methanogenic humans who are exposed to alkyl halides, although superficially at odds with the established view that patients with PCC are nonmethanogenic, 1 9 17 is supported by the in vitro work and by patients 1 and 2, who were methanogenic.
(Patient 3 was nonmethanogenic.)
In conclusion, exposure to chloral hydrate or related alkyl halides such as trichloroethylene is an important cause of super H 2 production in patients with PCC, and conversely the sharp decline in prescription rates for chloral sedation in Australia and elsewhere might explain the extreme rarity of PCC in the recent past. There may be other treatments in the pharmacopoeia which, by inhibiting bacterial consumption of H 2 , could also cause super H 2 production. Neomycin may be an example. It is a poorly absorbed antibiotic and is one of the few antibiotics that inhibit methanogens. 36 It has been described in association with PCC. 38 Bile acids spilling over into the colon might also be considered in the aetiology of PCC. Bile (acid) inhibits bacterial consumption of H 2 by methanogens and other H 2 -consuming bacteria in vitro, 23 32 thus greatly increasing H 2 . However, because bile acid accelerates colonic transit, which would wash out H 2 -producing bacteria, the conditions for PCC would not normally occur in the diarrhoeal state associated with excess bile acid. In this respect, it is pertinent that colonic transit has been shown to be normal or even slow in patients with PCC 14 despite the clinical symptoms of loose bowel movements and mucus.
It remains for us to consider the cause of secondary pneumatosis cystoides aVecting the small intestine in immunocompetent patients. In the series of Elliot, 7 pyloric obstruction occurred in 60% of cases, but the gas cysts were described in the jejunum. 1 In the detailed case description of ReinhoV and Collins, 3 the cysts were distal to the obstruction caused by a Crohn's stricture. In both descriptions, gastrointestinal obstruction was located proximally to the gas cysts. It is hypothesised that the two important aetiological factors in secondary pneumatosis cystoides are the presence of a proximal obstruction 1-3 7 (or pseudoobstruction 8 10 ) and H 2 production from bacterial overgrowth. 39 In health, about 15 ml of air is ingested with each swallow, and the portion of the swallowed gas that is not belched passes into the small intestine, 27 40 from where it is absorbed. N 2 entering the lumen would normally dilute gut luminal H 2 which is produced in the setting of bacterial overgrowth. Where gut obstruction occurs proximal to a locus of bacterial overgrowth, N 2 cannot enter via the lumen. If there is also a relative diVusion barrier to blood borne N 2 (see ref 20 )-a probable circumstance in elderly patients with vascular disease or patients with connective tissue disease 3 4 8 9 -then H 2 tension in the gut lumen could become equal to N 2 tension in the blood. In this setting, counterperfusion supersaturation of gases will occur in the gut wall, provided that the inherent unsaturation of tissue is small. 20 Metabolism of O 2 , which desaturates gas tension in tissue, 41 is the safety factor that could prevent gas bubbles forming more often. We are currently examining the eVect of reduced O 2 tension in the chloral hydrate rat model. Normal O 2 tension may explain the absence of PCC both in some persons with high luminal H 2 21 and in the rat model in spite of super H 2 production, whereas low O 2 tension in blood, which would result in small inherent unsaturation in tissue, could explain clinical associations between chronic lung disease 6 9 or vascular disease 3 4 8 9 and PCC. 
